Related Experiment Videos
Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis
1Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202, USA.
The Journal of Biological Chemistry
|August 15, 2001
Summary
Four splice variants of the SH2-B protein (PSM) mediate distinct cellular responses to growth factors like IGF-I and PDGF. These variants, identified through alternative splicing, play specific roles in mitogenic signaling pathways.
Area of Science:
- Molecular Biology
- Cell Signaling
- Genetics
Background:
- SH2-B, also known as PSM, is a cellular binding target for mitogenic receptors.
- PSM and its variants share structural similarities with APS and Lnk proteins.
- These mediators are involved in signaling pathways downstream of growth hormone and receptor tyrosine kinases.
Purpose of the Study:
- To identify and characterize PSM/SH2-B splice variants in mouse, rat, and human.
- To investigate the functional roles of these variants in mitogenic signaling pathways.
Main Methods:
- Identification of four PSM/SH2-B variants (alpha, beta, gamma, delta) through alternative splicing.
- Analysis of variant sequences and prediction of protein products.
- cDNA expression and phosphorylation studies in response to growth factors.
- Assessment of mitogenic responses to growth factor stimulation.
Main Results:
- Four distinct PSM/SH2-B splice variants were identified and characterized.
- All variants were phosphorylated upon IGF-I and PDGF stimulation.
- Variant-dependent stimulation of IGF-I- and PDGF-induced mitogenesis was observed, with gamma and delta showing the most pronounced effects.
- Epidermal growth factor stimulation did not affect mitogenic response.
Conclusions:
- Differential roles of PSM/SH2-B splice variants in specific mitogenic signaling pathways are implicated.
- The gamma and delta variants play a more significant role in promoting mitogenesis compared to alpha and beta.
- Understanding these variants provides insights into the complexity of growth factor signaling.